{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:14:43Z","timestamp":1791774883585,"version":"4.3.4"},"reference-count":97,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>This review focuses on the improved topical treatment of various medical skin conditions by the use of drugs delivered from carriers containing phospholipid soft vesicles. Topical drug delivery has many advantages over other ways of administration, having increased patient compliance, avoiding the first-pass effect following oral drug administration or not requesting multiple doses administration. However, the skin barrier prevents the access of the applied drug, affecting its therapeutic activity. Carriers containing phospholipid soft vesicles are a new approach to enhance drug delivery into the skin and to improve the treatment outcome. These vesicles contain molecules that have the property to fluidize the phospholipid bilayers generating the soft vesicle and allowing it to penetrate into the deep skin layers. Ethosomes, glycerosomes and transethosomes are soft vesicles containing ethanol, glycerol or a mixture of ethanol and a surfactant, respectively. We review a large number of publications on the research carried out in vitro, in vivo in animal models and in humans in clinical studies, with compositions containing various active molecules for treatment of skin medical conditions including skin infections, skin inflammation, psoriasis, skin cancer, acne vulgaris, hair loss, psoriasis and skin aging.<\/jats:p>","DOI":"10.3390\/pharmaceutics13122129","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:07:18Z","timestamp":1639102038000},"page":"2129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions"],"prefix":"10.3390","volume":"13","author":[{"given":"Elka","family":"Touitou","sequence":"first","affiliation":[{"name":"The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, P.O. Box 12065, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Natsheh","sequence":"additional","affiliation":[{"name":"The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, P.O. Box 12065, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10717540500455975","article-title":"Dermal and transdermal drug delivery systems: Current and future prospects","volume":"13","author":"Brown","year":"2006","journal-title":"Drug Deliv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2003.09.006","article-title":"Treatment of herpes simplex virus infections","volume":"61","author":"Brady","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-3084(97)00108-4","article-title":"The physical, chemical and functional properties of lipids in the skin and other biological barriers","volume":"91","author":"Wertz","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Touitou, E., and Barry, B.W. (2006). Enhancement in Drug Delivery, Taylor & Francis Group.","DOI":"10.1201\/9780849332036"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., and Maibach, H.I. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer.","DOI":"10.1007\/978-3-662-47862-2"},{"key":"ref_6","unstructured":"Smith, E.W., and Maibach, H.I. (1995). Percutaneous Penetration Enhancers, CRC Press."},{"key":"ref_7","unstructured":"Smith, E.W., and Maibach, H.I. (2006). Penetration Percutaneous Enhancers, Taylor and Francis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","article-title":"Penetration enhancers","volume":"56","author":"Williams","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zoabi, A., Touitou, E., and Margulis, K. (2021). Recent Advances in Nanomaterials for Dermal and Transdermal Applications. Colloids Interfaces, 5.","DOI":"10.3390\/colloids5010018"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes- novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_11","unstructured":"Touitou, E. (1998). Compositions for Applying Active Substances to or through the Skin. (5,716,638), U.S. Patent."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","article-title":"A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: Characterization and in vitro\/in vivo evaluation","volume":"92","author":"Song","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2013.07.060","article-title":"Glycerosomes: A new tool for effective dermal and transdermal drug delivery","volume":"455","author":"Manca","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2003.10.014","article-title":"Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier","volume":"94","author":"Godin","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1567201054367931","article-title":"Erythromycin ethosomal systems: Physicochemical characterization and enhanced antibacterial activity","volume":"2","author":"Godin","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13346-010-0006-y","article-title":"A new approach for skin tumor treatment: From delivery system characterization to in vivo evaluation","volume":"1","author":"Ainbinder","year":"2011","journal-title":"Drug Deliv. Trans. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Natsheh, H., and Touitou, E. (2020). Phospholipid Vesicles for Dermal\/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules, 25.","DOI":"10.3390\/molecules25132959"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","article-title":"Ethosomes: New prospects in transdermal delivery","volume":"20","author":"Godin","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1773-2247(07)50046-8","article-title":"Ethosomes for skin delivery","volume":"17","author":"Touitou","year":"2007","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"119398","DOI":"10.1016\/j.ijpharm.2020.119398","article-title":"What\u2019s new in the field of phospholipid vesicular nanocarriers for skin drug delivery","volume":"583","author":"Lai","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1567201815666180116091604","article-title":"Ethosomes as novel vesicular carrier: An overview of the principle, preparation and its applications","volume":"15","author":"Das","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.2174\/1381612822666160726123227","article-title":"Cubic phases, cubosomes and ethosomes for cutaneous application","volume":"22","author":"Esposito","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2174\/1381612825666190709210703","article-title":"Nanomedicines to treat skin pathologies with natural molecules","volume":"25","author":"Esposito","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.2174\/1381612825666190716095826","article-title":"Ethosomes for Dermal Administration of Natural Active Molecules","volume":"25","author":"Natsheh","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1517\/17425240903071029","article-title":"Vesicular carriers for dermal drug delivery","volume":"6","author":"Sinico","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.12.005","article-title":"Lipid vesicles for skin delivery of drugs: Reviewing three decades of research","volume":"332","author":"Elsayed","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1346-8138.1991.tb03122.x","article-title":"Pathogenesis and pathognesis-related treatment of acne","volume":"18","author":"Gollnick","year":"1991","journal-title":"J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0190-9622(95)90416-6","article-title":"New understanding of the pathogenesis of acne","volume":"32","author":"Leyden","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000067820","article-title":"Topical treatment in acne: Current status and future aspects","volume":"206","author":"Gollnick","year":"2003","journal-title":"Dermatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"American Academy of Dermatology\/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1468-3083.2007.02398.x","article-title":"Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris","volume":"22","author":"Touitou","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","first-page":"253","article-title":"Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study","volume":"55","author":"Esposito","year":"2004","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0159967","DOI":"10.1371\/journal.pone.0159967","article-title":"Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-021-02978-3","article-title":"Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: In vitro investigations and preclinical assessment","volume":"11","author":"Ansari","year":"2021","journal-title":"3 Biotech"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1079-2104(99)70164-2","article-title":"A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis","volume":"87","author":"Horwitz","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_36","first-page":"743","article-title":"Ethosomes for the delivery of anti-HSV-1 molecules: Preparation, characterization and in vitro activity","volume":"65","author":"Cortesi","year":"2010","journal-title":"Pharmazie"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/0250-474X.100253","article-title":"Colloidal dispersions for the delivery of acyclovir: A comparative study","volume":"73","author":"Cortesi","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vanti, G., Ntallis, S.G., Panagiotidis, C.A., Dourdouni, V., Patsoura, C., Bergonzi, M.C., Lazari, D., and Bilia, A.R. (2020). Glycerosome of Melissa officinalis L. Essential Oil for Effective Anti-HSV Type 1. Molecules, 25.","DOI":"10.3390\/molecules25143111"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/acsomega.7b00187","article-title":"Essential dynamics of an effective phototherapeutic drug in a nanoscopic delivery vehicle: Psoralen in ethosomes for biofilm treatment","volume":"2","author":"Bagchi","year":"2017","journal-title":"ACS Omega"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.colsurfb.2016.07.021","article-title":"Ethosomes for enhanced skin delivery of griseofulvin","volume":"146","author":"Marto","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jocd.12765","article-title":"Novel ethosomal gel of clove oil for the treatment of cutaneous candidiasis","volume":"18","author":"Shetty","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/08982104.2016.1239636","article-title":"Enhanced skin deposition and delivery of voriconazole using ethosomal preparations","volume":"28","author":"Faisal","year":"2018","journal-title":"J. Liposome Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/2211738506666180813122102","article-title":"Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment","volume":"6","author":"Verma","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3109\/03639045.2015.1132227","article-title":"Formulation and rheological evaluation of ethosome-loaded carbopol hydrogel for transdermal application","volume":"42","author":"Jain","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2005.04.007","article-title":"Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti inflammatory activity on human volunteers","volume":"106","author":"Paolino","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/08982100902722381","article-title":"Preparation of matrine ethosome, its percutaneous permeation in vitro and anti- inflammatory activity in vivo in rats","volume":"19","author":"Zhaowu","year":"2009","journal-title":"J. Liposome Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2013.11.017","article-title":"Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes","volume":"460","author":"Shen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10544-016-0134-3","article-title":"Ethosomes and organogels for cutaneous administration of crocin","volume":"18","author":"Esposito","year":"2016","journal-title":"Biomed. Microdevices"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"616810","DOI":"10.1155\/2013\/616810","article-title":"Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes","volume":"2013","author":"Ghanbarzadeh","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2016.07.009","article-title":"Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration","volume":"511","author":"Manca","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijpharm.2017.09.026","article-title":"Glycerosomes: Investigation of role of 1, 2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances","volume":"532","author":"Manca","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2147\/IJN.S135749","article-title":"Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: Optimization, characterization, and evaluation in vitro and in vivo","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fphar.2021.603227","article-title":"Development, Characterization and Stability Evaluation of Topical Gel Loaded with Ethosomes Containing Achillea millefolium L. Extract","volume":"12","author":"Andleeb","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2014.06.001","article-title":"Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy","volume":"471","author":"Zhang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/2211738507666190906123643","article-title":"Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis","volume":"7","author":"Chandra","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fathalla, D., Youssef, E.M.K., and Soliman, G.M. (2020). Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050446"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"120762","DOI":"10.1016\/j.ijpharm.2021.120762","article-title":"TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis","volume":"604","author":"Guo","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejpb.2012.02.008","article-title":"Paclitaxel-loaded ethosomes\u00ae: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses","volume":"81","author":"Paolino","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijpharm.2018.06.057","article-title":"Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model","volume":"548","author":"Rady","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Md, S., Alhakamy, N.A., Aldawsari, H.M., Husain, M., Khan, N., Alfaleh, M.A., Asfour, H.Z., Riadi, Y., Bilgrami, A.L., and Akhter, M.H. (2021). Plumbagin-Loaded Glycerosome Gel as Topical Delivery System for Skin Cancer Therapy. Polymers, 13.","DOI":"10.3390\/polym13060923"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0042-114034","article-title":"Ethosomal curcumin promoted wound healing and reduced bacterial flora in second degree burn in rat","volume":"66","author":"Partoazar","year":"2016","journal-title":"Drug Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s13346-017-0405-4","article-title":"Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: Biocompatibility, wound healing, and anti-bacterial effects","volume":"7","author":"Kianvash","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.2147\/IJN.S228863","article-title":"Ethosomal Gel for Improving Transdermal Delivery of Thymosin \u03b2-4","volume":"14","author":"Fu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10544-011-9590-y","article-title":"Ethosomes\u00ae and transfersomes\u00ae containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders","volume":"14","author":"Celia","year":"2012","journal-title":"Biomed. Microdevices"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","article-title":"Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: Formulation optimization, in vitro evaluation and preclinical assessment","volume":"24","author":"Garg","year":"2016","journal-title":"J. Drug Target"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003495-200161010-00006","article-title":"Treatments for Androgenetic Alopecia and Alopecia Areata","volume":"61","author":"Meidan","year":"2001","journal-title":"Drugs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.52711\/0974-360X.2021.00418","article-title":"Formulation, Design and Optimization of Glycerosomes for Topical Delivery of Minoxidil","volume":"14","author":"Rani","year":"2021","journal-title":"Res. J. Pharmacol. Technol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13596-020-00457-3","article-title":"Development of ethosome comprising combined herbal extracts and its effect on hair growth","volume":"21","author":"Madhunithya","year":"2021","journal-title":"Adv. Tradit. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clindermatol.2008.01.014","article-title":"Skin nonpenetrating sunscreens for cosmetic and pharmaceutical formulations","volume":"26","author":"Touitou","year":"2008","journal-title":"Clin. Dermatol."},{"key":"ref_70","first-page":"1","article-title":"Topical Delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles","volume":"3","author":"Jeswani","year":"2014","journal-title":"J. Pharm. Drug Deliv. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/02652048.2019.1617363","article-title":"Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes","volume":"36","year":"2019","journal-title":"J. Microencapsul."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pop.2015.08.006","article-title":"Viral skin diseases","volume":"42","author":"Ramdass","year":"2015","journal-title":"Prim. Care Clin. Off."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(82)90115-2","article-title":"Topical 5% acyclovir in polyethylene-glycol for herpes simplex labialis: Antiviral effect without clinical benefit","volume":"73","author":"Spruance","year":"1982","journal-title":"Am. J. Med."},{"key":"ref_74","first-page":"135","article-title":"Herpes labialis treatment with acyclovir 5% ointment","volume":"55","author":"Raborn","year":"1989","journal-title":"J. Can. Dent. Assoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2133.1983.tb03548.x","article-title":"Topical acyclovir in the management of herpes labialis","volume":"109","author":"Fiddian","year":"1983","journal-title":"Br. J. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0030-4220(89)90007-8","article-title":"Herpes labialis treatment with acyclovir 5% modified aqueous cream: A double blind randomized trial","volume":"67","author":"Raborn","year":"1989","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/S0142-9612(01)00052-7","article-title":"Intracellular delivery mediated by an ethosomal carrier","volume":"22","author":"Touitou","year":"2001","journal-title":"Biomaterials"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2165\/00003495-200363140-00003","article-title":"A practical guide to the treatment of complicated skin and soft tissue infections","volume":"63","author":"Fung","year":"2003","journal-title":"Drugs"},{"key":"ref_80","first-page":"2424","article-title":"Skin and wound infections: An overview","volume":"57","year":"1998","journal-title":"Am. Fam. Physician"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/44.suppl_1.19","article-title":"Optimal treatment of complicated skin and skin structure infections","volume":"44","author":"Nichols","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/14787210.2014.960849","article-title":"Fungal infections of the skin and nail: New treatment options","volume":"12","author":"Eldridge","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Zhang, L., Li, X., Zhu, S., Zhang, T., Maimaiti, A., Ding, M., and Shi, S. (2020). Dermal Targeting Delivery of Terbinafine Hydrochloride Using Novel Multi-Ethosomes: A New Approach to Fungal Infection Treatment. Coatings, 10.","DOI":"10.3390\/coatings10040304"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2006.03261.x","article-title":"Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation","volume":"147","author":"Nielsen","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: Clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/08982100903544144","article-title":"Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model","volume":"20","author":"Chen","year":"2010","journal-title":"J. Liposome Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clindermatol.2007.08.007","article-title":"Psoriasis: Epidemiology","volume":"25","author":"Gudjonsson","year":"2007","journal-title":"Clin. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2015.07.006","article-title":"Skin cancer","volume":"42","author":"Linares","year":"2015","journal-title":"Prim. Care"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_91","first-page":"357","article-title":"Early detection and treatment of skin cancer","volume":"62","author":"Jerant","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma","volume":"54","author":"Rendon","year":"2006","journal-title":"Am. Acad. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Vitiligo","volume":"360","author":"Picardo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000454919","article-title":"Skin wound healing: An update on the current knowledge and concepts","volume":"58","author":"Sorg","year":"2017","journal-title":"Eur. Surg. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Farage, M.A., Miller, K.W., and Maibach, H.I. (2016). Skin photodamage prevention: State of the art and new prospects. Textbook of Aging Skin, Springer.","DOI":"10.1007\/978-3-642-27814-3"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Sguizzato, M., Mariani, P., Spinozzi, F., Benedusi, M., Cervellati, F., Cortesi, R., Drechsler, M., Prieux, R., Valacchi, G., and Esposito, E. (2020). Ethosomes for Coenzyme Q10 Cutaneous Administration: From Design to 3D Skin Tissue Evaluation. Antioxidants, 9.","DOI":"10.3390\/antiox9060485"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:44:35Z","timestamp":1760168675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":97,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["pharmaceutics13122129"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13122129","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]}}}